| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $631.4M | +11.4% |
| Cost of Revenue | $254.1M | +5.6% |
| Gross Profit | $377.3M | +15.7% |
| R&D Expense | $0 | — |
| SG&A Expense | $210.4M | +32.1% |
| Operating Income | $169.9M | +1.8% |
| Pre-tax Income | $98.6M | +30.2% |
| Income Tax | $29.4M | +6.5% |
| Net Income | $69.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.6M | -70.5% |
| Short-term Investments | $92.2M | +28.8% |
| Accounts Receivable | $228.5M | +27.3% |
| Inventory | $35.6M | +10.0% |
| Current Assets | $482.3M | -10.3% |
| Total Assets | $1.66B | +45.5% |
| Current Liabilities | $509.5M | +11.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $205.0M | -25.4% |
| Capital Expenditures | $1.7M | +258.4% |
| Investing Cash Flow | -$287.8M | -306.4% |
| Financing Cash Flow | -$60.6M | +56.8% |
| Free Cash Flow | $203.3M | -25.9% |
| +43.7% |
| EPS (Basic) | $2.14 | +49.7% |
| EPS (Diluted) | $1.86 | +44.2% |
| Total Liabilities |
| $1.43B |
| +51.4% |
| Stockholders' Equity | $228.8M | +17.1% |